Valuation : Ipsen

Market Cap 1.34TCr 1.55TCr 1.26TCr 1.15TCr 2.15TCr 1,47800Cr 2.17TCr 15TCr 5.79TCr 75TCr 5.83TCr 5.7TCr 2,48100Cr P/E 2026 *
13.6x
P/E 2027 * 13.9x
Enterprise Value 1.21TCr 1.41TCr 1.14TCr 1.04TCr 1.95TCr 1,34100Cr 1.97TCr 14TCr 5.25TCr 68TCr 5.29TCr 5.18TCr 2,25200Cr EV / Sales 2026 *
2.67x
EV / Sales 2027 * 2.39x
Free-Float
40.65%
Yield 2026 *
0.94%
Yield 2027 * 0.94%
1 day-3.87%
1 week+0.25%
Current month-5.30%
1 month-5.30%
3 months+6.41%
6 months-1.21%
Current year+37.07%
1 week 162.7
Extreme 162.7
169.1
1 month 153.8
Extreme 153.8
169.1
Current year 116.5
Extreme 116.5
172.7
1 year 110.9
Extreme 110.9
172.7
3 years 90.2
Extreme 90.2
172.7
5 years 77.76
Extreme 77.76
172.7
10 years 36.84
Extreme 36.84
172.7
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Change 5-day change 1-year change 3-year change Capi.($)
-3.87%+0.25% - - 1.55TCr
-1.66%-7.36%+57.12%+108.44% 1,04700Cr
-0.62%-2.48%+49.55%+64.70% 65TCr
+0.64%-2.99%+21.09%+74.61% 45TCr
-1.64%-4.75%+35.59%+35.54% 35TCr
-0.39%-2.76%+21.39%+38.01% 29TCr
-1.19%-2.21%+1.53%+11.51% 25TCr
-0.54%-3.05%+49.97%+67.86% 23TCr
-1.05%-2.29%-19.91%-54.10% 20TCr
+0.39%-0.31%+29.79%+91.28% 18TCr
Average -1.12%-2.68%+27.35%+48.65% 40.66TCr
Weighted average by Cap. -0.99%-3.46%+36.51%+64.75%

Financials

2026 *2027 *
Net sales 454.34Cr 527.69Cr 426.61Cr 389.43Cr 731.58Cr 50TCr 736.82Cr 5.06TCr 1.97TCr 25TCr 1.98TCr 1.94TCr 84TCr 463.7Cr 538.56Cr 435.4Cr 397.44Cr 746.64Cr 51TCr 751.99Cr 5.16TCr 2.01TCr 26TCr 2.02TCr 1.98TCr 86TCr
Net income 101.07Cr 117.39Cr 95Cr 87Cr 162.74Cr 11TCr 163.91Cr 1.12TCr 437.54Cr 5.66TCr 440.75Cr 431.18Cr 19TCr 99Cr 114.45Cr 93Cr 84Cr 158.67Cr 11TCr 159.8Cr 1.1TCr 426.58Cr 5.52TCr 429.72Cr 420.38Cr 18TCr
Net Debt -123.8Cr -143.79Cr -116.24Cr -106.11Cr -199.34Cr -14TCr -200.77Cr -1.38TCr -535.93Cr -6.94TCr -539.87Cr -528.14Cr -23TCr -229.94Cr -267.07Cr -215.91Cr -197.09Cr -370.25Cr -25TCr -372.9Cr -2.56TCr -995.43Cr -13TCr -1TCr -980.96Cr -43TCr
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change
31/26/31 162.70 -3.78%
28/26/28 €169.10 +1.99%
27/26/27 €165.80 +0.18%
26/26/26 €165.50 +0.73%
25/26/25 €164.30 +1.23%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
163.10EUR
Average target price
167.07EUR
Spread / Average Target
+2.43%

Quarterly revenue - Rate of surprise